跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRETARIS GENUAIR aclidinium (as bromide) 322 micrograms powder for inhalation inhaler - dry powder - TGA Drug Approval Details
Approvals
/
TGA
/
BRETARIS GENUAIR aclidinium (as bromide) 322 micrograms powder for inhalation inhaler - dry powder
Approved
STANDARD
BRETARIS GENUAIR aclidinium (as bromide) 322 micrograms powder for inhalation inhaler - dry powder
A Menarini Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
264b63d8d05d4a22
Company
A Menarini Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
264b63d8d05d4a22
Product Name
BRETARIS GENUAIR aclidinium (as bromide) 322 micrograms powder for inhalation inhaler - dry powder
Artg Id
206071
Artg Name
BRETARIS GENUAIR aclidinium (as bromide) 322 micrograms powder for inhalation inhaler - dry powder
Sponsor
A Menarini Australia Pty Ltd
Artg Date
2014-03-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4c963451af4bec2386ddfb14a494b4c8.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/cd5ec8e9643b7c0f0a75996ddad59e70.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
264b63d8d05d4a22
Type
Standard
Back to TGA Approvals